This article develops a generic conceptual framework for defining and valid
ating the concept of minimal clinically important difference. We propose 3
approaches. The first uses statistical descriptions of the population ("dis
tribution based"), the second relies on experts ("opinion based"), and a th
ird is based on sequential hypothesis formation and testing ("predictive/da
ta driven based"). The first 2 approaches serve as proxies for the third, w
hich is an experimentally driven approach, asking such questions as "What c
arries the least penalty?" or "What imparts the greatest gain?" As an exper
imental approach, it has the expected drawbacks, including the need for gre
ater resources, and the need to tolerate trial and error en route. compared
to the other 2 models.